The Global Aminoglycosides Market is estimated to be valued at USD 2.04 Bn in 2026 and is expected to reach USD 3.09 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033. This consistent growth is driven by rising demand stemming from the increasing prevalence of infectious diseases and the continued use of aminoglycoside antibiotics in clinical practice worldwide.
Request a Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/9140
Global Aminoglycosides Market Key Takeaways
Gentamicin is likely to remain the most sought-after drug type, accounting for 30.1% share in 2026.
Based on application, bacterial infections segment is slated to hold 32.4% of the global aminoglycosides market share in 2026.
By dosage form, parenteral segment is set to dominate the market with a 43.4% share in 2026.
North America is expected to dominate the global aminoglycosides industry, holding a share of 41. 4% in 2026.
Asia Pacific, with an estimated share of 24. 2% in 2026, is anticipated to emerge as the most lucrative pocket for aminoglycoside manufacturers during the forecast period.
Rising Prevalence of Bacterial Infections Spurring Aminoglycosides Market Growth
Coherent Market Insights’ latest aminoglycosides market analysis highlights key factors driving industry growth. Increasing incidence of bacterial infections, growing awareness of antimicrobial resistance (AMR), expanding healthcare infrastructure, and advancements in drug formulations are some of the major aminoglycosides market growth factors.
Bacterial infections like urinary tract infections (UTIs), tuberculosis, respiratory infections, and gastrointestinal infections are becoming common globally. According to The Lancet, around 7.7 million people die annually from bacterial infections. This growing incidence and mortality rates are fueling demand for aminoglycosides such as Gentamicin, Tobramycin, Streptomycin, and Neomycin.
Aminoglycosides are strong antibiotics that kill bacteria and work well against Gram-negative bacteria. This is making them essential in treating serious infections such as respiratory diseases, UTIs, ventilator-associated pneumonia, and hospital-acquired infections (HAIs). Thus, surge in cases of these health conditions is expected to boost growth of aminoglycosides market during the forecast period.
Also Read: Oral Antibiotics Market Size, Share, Trends & Opportunities for 2025-2032
Safety Concerns and Antibiotic Resistance Limited Market Growth
The global aminoglycosides market outlook remains promising, owing to increasing prevalence of bacterial infections and growing usage of aminoglycoside antibiotics. However, rising safety concerns and growing antimicrobial resistance might slow down market growth to some extent during the forecast period.
Aminoglycosides can cause serious side effects, especially kidney damage and hearing loss. Because of these risks, their use is limited, particularly in sensitive groups like older adults, children, and patients who already have kidney problems. When safer antibiotics are available, doctors usually choose them instead, which reduces overall demand aminoglycosides market demand.
The increasing prevalence of antibiotic-resistant bacteria also hampers aminoglycosides market growth. Many pathogens have developed resistance mechanisms to aminoglycosides, reducing their effectiveness and leading clinicians to avoid or limit their use. Regulatory and stewardship programs aimed at curbing antibiotic misuse also reduce prescription volumes.
Buy the Complete Report with an Impressive Discount (Up to 40% Off ) at: https://www.coherentmarketinsights.com/offernew/buy-now/9140
Advances in Drug Formulations Unlocking New Growth Opportunities
Advances in drug formulations, such as inhalable aminoglycoside therapies and liposomal or other targeted delivery systems, are making aminoglycosides safer and more effective. These innovations are allowing their use in more clinical situations, especially for difficult-to-treat infections. They are also expected to create profitable growth opportunities for manufacturers of aminoglycoside during the forecast period.
Moreover, increasing veterinary and animal health applications will likely boost sales of aminoglycosides during the forecast period. Aminoglycosides are not only used in human medicine but also widely in veterinary medicine to treat animal infections, livestock disease outbreaks, and companion animal care.
Emerging Aminoglycosides Market Trends
Shift towards combination treatment approaches is fueling demand for aminoglycosides. Aminoglycosides are increasingly used in combination with other antibiotics like beta-lactams to tackle complex and drug-resistant infections more effectively.
Despite being a growth-limiting factor, antimicrobial resistance (AMR) is also influencing demand trends in the aminoglycosides market. As resistance lowers the effectiveness of many first-line antibiotics, healthcare providers are increasingly using aminoglycosides for severe and hospital-acquired infections. This selective and targeted use helps maintain steady demand and positions aminoglycosides as important treatment options against resistant pathogens.
Rising incidence of hospital-acquired infections (HAIs), especially in ICUs and post-surgical settings, fuels aminoglycoside utilization because of their rapid, broad-spectrum action. They are widely used for ventilator-associated pneumonia, bloodstream infections, and other serious conditions.
There is a rising trend toward targeted aminoglycoside delivery, including inhalable formulations for respiratory infections and site-specific drug systems. These advanced therapies improve effectiveness at infection sites while reducing systemic toxicity, supporting market growth.
Generic drug accessibility is playing a key role in improving the aminoglycosides market value. Many aminoglycoside antibiotics are available as generic drugs, which reduces cost as well as improves accessibility, especially in developing markets. This affordability supports broader use.
Also Read: Global Tobramycin Eye Drop Market Outlook for 2025-2032
Analyst’s View
“The global aminoglycosides market is projected to grow steadily, driven by the rising burden of severe bacterial infections, increasing use of combination antibiotic therapies, ongoing demand for cost-effective broad-spectrum antibiotics, and rising adoption across hospital, clinical, and veterinary settings,” said the senior analyst at CMI.
Current Events and Their Impact on the Aminoglycosides Market
|
Event |
Description and Impact |
|
Rising Antimicrobial Resistance (AMR) Crisis |
|
|
Technological Advances in Drug Delivery and Formulation |
|
Competitor
Insights Key
companies listed in the aminoglycosides market report include: - Cipla
Limited - Pfizer
Inc. - Novartis
AG - AbbVie
Inc. (Allergan PLC) - Teva
Pharmaceutical Industries Ltd - Bristol
Myers Squibb Company - Johnson
& Johnson - Vega
Pharma Ltd - Yi
Chang Veterinary Medicine Factory - Kremoint
Pharma Pvt Ltd - Insmed
Incorporated - Xian
Wison Biological Technology Co Ltd - Sun
Pharmaceutical Industries Limited - Chiesi
Farmaceutici - Medson
Pharmaceuticals Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/9140
Key
Developments ·
In May 2025, Cipla
Limited launched ZEMDRI (Plazomicin), a novel intravenous aminoglycoside in
India for the treatment of complicated urinary tract infections (cUTI). ZEMDRI
is designed to help treat infections caused by drug-resistant Gram-negative
bacteria. ·
In February 2025, the
U.S. FDA approved AbbVie’s EMBLAVEO (aztreonam and avibactam) for the treatment
of adults with complicated intra-abdominal infections. Market Segmentation Drug Type Insights
(Revenue, USD Bn, 2021 - 2033) Application Insights
(Revenue, USD Bn, 2021 - 2033) Dosage Form Insights
(Revenue, USD Bn, 2021 - 2033) End User Insights
(Revenue, USD Bn, 2021 - 2033) Distribution Channel
Insights (Revenue, USD Bn, 2021 - 2033) Regional Insights
(Revenue, USD Bn, 2021 - 2033) Also Read: Bacterial
Vaccines Market Size, Share & Trend Analysis Report for 2025-2032 Our
Trusted Partners: Worldwide
Market Reports, Coherent MI,
Stratagem
Market Insights Get
Recent News: https://www.coherentmarketinsights.com/news About Us: Coherent Market Insights leads into data
and analytics, audience measurement, consumer behaviors, and market trend
analysis. From shorter dispatch to in-depth insights, CMI has exceled in
offering research, analytics, and consumer-focused shifts for nearly a decade.
With cutting-edge syndicated tools and custom-made research services, we
empower businesses to move in the direction of growth. We are multifunctional
in our work scope and have 450+ seasoned consultants, analysts, and researchers
across 26+ industries spread out in 32+ countries.
Contact Us:
Mr. Shah Coherent Market Insights Pvt. Ltd, U.S.: + 12524771362 U.K.: +442039578553 AUS: +61-8-7924-7805 INDIA: +91-848-285-0837 ✉
Email: sales@coherentmarketinsights.com
